Eliquent Japan

Shinjuku, Japan Founded: 2003 • Age: 23 yrs Acquired By Validant
Regulatory and consulting services are provided to the biopharma sector.
Request Access

About Eliquent Japan

Eliquent Japan is a company based in Shinjuku (Japan) founded in 2003 by Chris Brunger was acquired by Validant in November 2020. It operates as a Professional Services. Eliquent Japan offers products and services including PMDA Consultations, Orphan Drug Designation, and NDA Filing. Eliquent Japan operates in a competitive market with competitors including Indegene, IntegriChain, Clinigen, Zuellig Pharma and Science Group, among others.

  • Headquarter Shinjuku, Japan
  • Founders Chris Brunger
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Eliquent Japan, Inc.
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Validant

    (Nov 24, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Eliquent Japan

Eliquent Japan offers a comprehensive portfolio of products and services, including PMDA Consultations, Orphan Drug Designation, and NDA Filing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Communication strategies with PMDA are developed and supported.

Support for orphan drug designation strategies is provided.

Comprehensive support for Japan NDA filing is offered.

People of Eliquent Japan
Headcount 10-50
Employee Profiles 4
Employee Profiles
People
Masayoshi Takezawa
Deputy Director Of Business Development

Unlock access to complete

Teams

Funding Insights of Eliquent Japan

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Eliquent Japan

Eliquent Japan has secured backing from 1 investor. Prominent investors backing the company include Validant. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Regulatory, compliance, and quality consulting for GxP lifecycles is provided.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Eliquent Japan

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Eliquent Japan

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Eliquent Japan Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Eliquent Japan

Eliquent Japan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, IntegriChain, Clinigen, Zuellig Pharma and Science Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Suite solutions are provided for payers and healthcare providers.
domain founded_year HQ Location
Inventory, order and customer relationship management solution for life science suppliers.
domain founded_year HQ Location
Specialty medicines are supplied via clinical trials and access programs.
domain founded_year HQ Location
Healthcare access in Asia is enhanced by Zuellig Pharma.
domain founded_year HQ Location
Technology-based consultancy and product development services are provided.
domain founded_year HQ Location
Strategic consulting services are provided to life sciences companies.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Eliquent Japan

Frequently Asked Questions about Eliquent Japan

When was Eliquent Japan founded?

Eliquent Japan was founded in 2003.

Where is Eliquent Japan located?

Eliquent Japan is headquartered in Shinjuku, Japan. It is registered at Shinjuku, Tokyo, Japan.

Who is the current CEO of Eliquent Japan?

Naoya Kato is the current CEO of Eliquent Japan.

What does Eliquent Japan do?

Eliquent Japan is engaged in offering regulatory consulting services to biotech and pharmaceutical companies aiming to enter the Japanese market. Support is provided through PMDA consultations, orphan drug designations, and NDA filings. Expertise in Japanese regulations and bilingual communication is utilized to ensure seamless development and approval processes. Services cover early-stage evaluations, approval applications, and post-marketing lifecycle management, addressing the unique needs of clients in the biotechnology and pharmaceutical sectors.

Who are the top competitors of Eliquent Japan?

Eliquent Japan's top competitors include Indegene, Zuellig Pharma and IntegriChain.

What products or services does Eliquent Japan offer?

Eliquent Japan offers PMDA Consultations, Orphan Drug Designation, and NDA Filing.

Who are Eliquent Japan's investors?

Eliquent Japan has 1 investor. Key investors include Validant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available